JPMORGAN CHASE & CO

VYLD

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 6,113Value: $2.0M

**Signal Note: Driehaus Initiates JPMorgan Chase Position** This $2.0M position in JPMorgan Chase appears misaligned with Driehaus's stated biotech focus and likely reflects either a portfolio rebalancing, hedge, or data error rather than a biotech-specific thesis. JPMorgan Chase is a financial services company without direct drug development exposure; if Driehaus intended biotech exposure, this warrant closer scrutiny for accuracy.

More VYLD Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: